+987.9%
MRNA vs FCEL
+32.6%
+955.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FCEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -6.0% | +19.1% | +13.6% |
| 7D | +20.6% | -14.9% | +35.5% | +22.1% |
| 30D | +27.1% | -41.7% | +68.8% | +31.9% |
| 3M | +353.4% | -53.2% | +406.5% | +375.6% |
| 6M | +446.3% | -19.0% | +465.3% | +410.8% |
| YTD | +776.2% | +44.2% | +732.0% | +633.0% |
| 1Y | +987.9% | +42.4% | +945.5% | +783.2% |
| All | +987.9% | +32.6% | +955.3% | +783.2% |
Cumulative growth
Daily Returns
Daily percentage return beside FCEL.
Daily Out/Under-Performance
Portfolio return minus FCEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FCEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling